The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((5-((3-cyano-6-methyl-2-oxopyridin-1(2H)-yl)methyl)-4-(3-phenylpropyl)-4H-1,2,4-triazol-3-yl)thio)-N-cyclopentylacetamide ID: ALA4524289
PubChem CID: 155520105
Max Phase: Preclinical
Molecular Formula: C26H30N6O2S
Molecular Weight: 490.63
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(C#N)c(=O)n1Cc1nnc(SCC(=O)NC2CCCC2)n1CCCc1ccccc1
Standard InChI: InChI=1S/C26H30N6O2S/c1-19-13-14-21(16-27)25(34)32(19)17-23-29-30-26(35-18-24(33)28-22-11-5-6-12-22)31(23)15-7-10-20-8-3-2-4-9-20/h2-4,8-9,13-14,22H,5-7,10-12,15,17-18H2,1H3,(H,28,33)
Standard InChI Key: XYNFUZHCEMRTDB-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
4.4976 -9.8879 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7570 -10.6710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5650 -10.8379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9042 -11.5868 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7241 -11.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8909 -10.6877 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1740 -10.2796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4960 -12.3037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9128 -13.0157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5046 -13.7327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9245 -14.4391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2797 -12.1057 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.0856 -11.9294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6413 -12.5393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4472 -12.3631 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3909 -13.3254 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0028 -12.9730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5208 -15.1543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9400 -15.8603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7626 -15.8504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1643 -15.1286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7428 -14.4256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8389 -13.7783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5558 -14.1867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1657 -13.6310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8256 -12.8794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0458 -9.2707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7893 -8.4904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9819 -8.3193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4314 -8.9351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6882 -9.7218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1388 -10.3372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6221 -8.7684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8148 -8.5989 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8537 -9.4382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 3 2 0
4 8 1 0
8 9 1 0
9 10 1 0
11 10 1 0
5 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
11 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 11 1 0
17 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 17 1 0
1 27 1 0
1 31 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
33 34 3 0
30 33 1 0
27 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 490.63Molecular Weight (Monoisotopic): 490.2151AlogP: 3.45#Rotatable Bonds: 10Polar Surface Area: 105.60Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.06CX LogP: 2.91CX LogD: 2.91Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.44Np Likeness Score: -2.16
References 1. Roberti M, Schipani F, Bagnolini G, Milano D, Giacomini E, Falchi F, Balboni A, Manerba M, Farabegoli F, De Franco F, Robertson J, Minucci S, Pallavicini I, Di Stefano G, Girotto S, Pellicciari R, Cavalli A.. (2019) Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells., 165 [PMID:30660828 ] [10.1016/j.ejmech.2019.01.008 ]